Enhanced p22phoxexpression impairs vascular function through p38 and ERK1/2 MAP kinase-dependent mechanisms in type 2 diabetic mice
- 1 April 2014
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 306 (7) , H972-H980
Abstract
Type 2 diabetes is associated with vascular complication. We hypothesized that increased nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunit p22phoxexpression impairs vascular endothelium-dependent relaxation (EDR) in type 2 diabetes. Type 2 diabetic ( db−/db−) and control ( db−/db+) mice were treated with reactive oxygen species (ROS) scavenger, polyethylene glycol superoxide dismutase (1,000 U/kg daily ip), or small interfering RNA p22phox(p22phox-lentivirus-small interfering RNA, 100 μg iv, 2 times/wk) for 1 mo. EDR was impaired in microvascular bed (coronary arteriole and femoral and mesenteric resistance arteries) from diabetic mice compared with control. Interestingly, ROS scavenger and p22phoxdownregulation did not affect blood glucose level or body weight but significantly improved EDR. Mitogen-activated protein kinases (ERK1/2 and p38) phosphorylation and NADPH oxidase activity were increased in arteries from diabetic mice and were reduced after ROS scavenger or p22phoxdownregulation in db−/db−mice. The present study showed that enhanced p22phoxexpression causes vascular dysfunction through ERK1/2 and p38-mitogen-activated protein kinase-dependent mechanisms in male type 2 diabetic mice. Therefore, p22phoxcould be an important target to improve vascular function in diabetes.Keywords
This publication has 51 references indexed in Scilit:
- Poly(ADP-Ribose) Polymerase 1 Inhibition Improves Coronary Arteriole Function in Type 2 Diabetes MellitusHypertension, 2012
- Chronic Inhibition of Epidermal Growth Factor Receptor Tyrosine Kinase and Extracellular Signal-Regulated Kinases 1 and 2 (ERK1/2) Augments Vascular Response to Limb Ischemia in Type 2 Diabetic MiceThe American Journal of Pathology, 2012
- Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress–Induced Insulin Resistance in Cardiac Cells In Vitro and In VivoDiabetes, 2011
- Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic CardiomyopathyJACC, 2010
- α1‐Adrenoceptor‐mediated contraction of rat aorta is partly mediated via transactivation of the epidermal growth factor receptorBritish Journal of Pharmacology, 2010
- Enhancement of mesenteric artery contraction to 5‐HT depends on Rho kinase and Src kinase pathways in theob/obmouse model of type 2 diabetesBritish Journal of Pharmacology, 2010
- Inhibition of p38 MAPK reverses hypoxia-induced pulmonary artery endothelial dysfunctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- AGE/RAGE produces endothelial dysfunction in coronary arterioles in Type 2 diabetic miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Elevated Epidermal Growth Factor Receptor Phosphorylation Induces Resistance Artery Dysfunction in Diabetic db/db MiceDiabetes, 2008
- Nitric Oxide and Peroxynitrite in Health and DiseasePhysiological Reviews, 2007